Palwinder Singh

Developing Deloitte UK's Life Sciences & Healthcare GxP Computer System Validation capability within the Engineering, AI & Data division. Defined SDLC strategy for a pharma client's GxP R&D systems and set validation strategy for a 14-site MES deployment.

Owned qualification and lifecycle of all computerised systems at an API manufacturing site, including production, QC laboratory, and supply chain systems. Managed change control, data integrity remediation, and audit readiness for MHRA and FDA inspections.

Project-managed retrospective validation of a legacy DCS from non-GxP to GxP manufacture, authoring full documentation set and applying GAMP 5 principles. Managed a team of 5 senior validation engineers across concurrent projects.

Validated a vendor-supplied SaaS eBMR platform across three global sites, including validation plans, risk assessments, and user acceptance testing. Led time-critical quarterly SaaS upgrades in the GMP environment.

Led Phase 1 validation strategy and Validation Plan for a laboratory equipment transfer at Bristol Myers Squibb, with milestone tracking and client training in Kneat validation lifecycle management.

Validated FBRM instrumentation into an existing system at AstraZeneca, producing validation documentation including RID, Computer Validation Plan, URS, and Design Qualification.

Provided process control system validation expertise for technical transfer to automated packing lines at Terumo Aortic, writing functional specifications and risk-assessing software upgrade paths.

Developed and executed IQ/OQ/PQ protocols, VSRs, SOPs, and risk assessments for technical transfers and equipment introduction under GMP. Site SME for serialisation, validating coding and labelling equipment to EU FMD and UDI standards.

Grade: 2:1

Bachelor of Engineering (Honours) in Petroleum Engineering with a 2:1 classification.

Grade: Merit

Higher National Diploma in Chemical Engineering with Merit, completed from 2013 to 2017.